We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.77%
2 Consumer Discretionary 1.94%
3 Technology 1.9%
4 Communication Services 1.42%
5 Financials 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GALT icon
10776
CALL
Galectin Therapeutics
GALT
$418M
$286K ﹤0.01%
89,400
+76,700
+604% +$273K
GSBC icon
10777
Great Southern Bancorp
GSBC
$856M
$286K ﹤0.01%
+5,301
New +$297K
HVT icon
10778
PUT
Haverty Furniture Companies
HVT
$427M
$286K ﹤0.01%
6,700
-500
-7% -$21.9K
PTH icon
10779
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$276M
$286K ﹤0.01%
5,160
-44,742
-90% -$2.33M
QTEC icon
10780
PUT
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.83B
$286K ﹤0.01%
1,800
RAPT
10781
DELISTED
RAPT Therapeutics
RAPT
$286K ﹤0.01%
1,124
-1,564
-58% -$292K
RPV icon
10782
CALL
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
$286K ﹤0.01%
3,700
-200
-5% -$15.6K
STTK icon
10783
Shattuck Labs
STTK
$768M
$286K ﹤0.01%
+9,864
New +$288K
TACT icon
10784
Transact Technologies
TACT
$52.4M
$286K ﹤0.01%
20,856
+3,964
+23% +$50.5K
VECO icon
10785
PUT
Veeco
VECO
$2.87B
$286K ﹤0.01%
11,900
-499,100
-98% -$11.4M
NBSE
10786
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$286K ﹤0.01%
+2,990
New +$330K
ANAB icon
10787
CALL
AnaptysBio
ANAB
$1.7B
$285K ﹤0.01%
11,000
-4,600
-29% -$110K
ASYS icon
10788
PUT
Amtech Systems
ASYS
$277M
$285K ﹤0.01%
29,600
+16,800
+131% +$172K
BKD icon
10789
Brookdale Senior Living
BKD
$2.89B
$285K ﹤0.01%
36,074
+10,207
+39% +$73.4K
PCOR icon
10790
PUT
Procore
PCOR
$9.68B
$285K ﹤0.01%
+3,000
New +$263K
THG icon
10791
CALL
Hanover Insurance
THG
$7.93B
$285K ﹤0.01%
2,100
NS
10792
DELISTED
NuStar Energy L.P.
NS
$285K ﹤0.01%
15,810
-13,557
-46% -$251K
ROCC
10793
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$285K ﹤0.01%
12,089
-57,648
-83% -$1.05M
MNRL
10794
PUT
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$285K ﹤0.01%
+13,400
New +$244K
AVA icon
10795
Avista
AVA
$3.16B
$284K ﹤0.01%
6,649
-106,108
-94% -$4.86M
DWCR
10796
DELISTED
Arrow DWA Country Rotation ETF
DWCR
$284K ﹤0.01%
7,977
-869
-10% -$30.3K
ILF icon
10797
PUT
iShares Latin America 40 ETF
ILF
$3.76B
$284K ﹤0.01%
9,000
-6,600
-42% -$198K
ITT icon
10798
CALL
ITT
ITT
$18.6B
$284K ﹤0.01%
3,100
-5,700
-65% -$531K
JAGX icon
10799
Jaguar Health
JAGX
$4.47M
0
MFLX icon
10800
First Trust Exchange-Traded Fund VIII First Trust Flexible Municipal High Income ETF
MFLX
$21M
$284K ﹤0.01%
13,313
-29,012
-69% -$605K

Similar funds

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.